MINNEAPOLIS–(BUSINESS WIRE)–Interrad Medical, Inc.
a privately held medical device company, announced today that it has received
FDA clearance for four new sizes of the SecurAcath subcutaneous catheter
securement device. In response to requests from clinicians throughout the US, Canada
and Europe, the SecurAcath is now available to
secure 3, 4, 5, 6, 7, 8 French size intravenous catheters.
There are over 500 million intravenous access catheters
placed each year worldwide. Currently, vascular access catheters are secured on
the surface of a patient’s skin using sutures or adhesive devices. The
SecurAcath is the only catheter securement device that does not require sutures
or adhesives, enabling fast, safe, and continuous securement. The unique design
of the SecurAcath secures and stabilizes catheters right at the insertion site
using a small, blunt anchor that deploys and holds virtually painlessly in the
subcutaneous tissue just beneath the skin. The device takes only seconds to
place and seconds to remove, and secures for the life of the catheter. The
SecurAcath is also designed to prevent catheter migration and pistoning, and
allows for 360 degree site cleaning while secured.
The SecurAcath offers significant advantages over current
securement and stabilization methods. The device can reduce costs by decreasing
the time required to secure, maintain and remove catheters. The device design
allows for improved catheter site cleaning and minimizes catheter motion which
may reduce catheter-related infections. Finally, the SecurAcath is sutureless,
therefore, it eliminates the potential for needlestick injuries that can occur
when suturing catheters.
Joe Goldberger, Interrad’s President and CEO commented,
“Expanding from two to six sizes allows clinicians to use the SecurAcath on a
wider range of catheters to meet their patients’ needs, and allows broader use
throughout the hospital.”
The SecurAcath device is currently available in the US, Canada,
and parts of Europe, in 3F to 8F sizes for use
with intravenous catheters. The Company plans to expand indications and
catheter platforms the SecurAcath works on in the coming months. Ultimately,
the SecurAcath has the potential to become the next standard of care for
About Interrad Medical, Inc.
based Interrad Medical, Inc. is a developer, manufacturer and marketer of
medical devices, designed for minimally-invasive interventional and surgical
procedures. The Company was founded by practicing Interventional Radiologist
and Interrad Medical Chairman and Chief Medical Officer, Michael Rosenberg,
M.D. For more information, visit www.securacath.com.